Pharmaceuticals · PLYMOUTH MEETING, PA, United States
$1.21
-2.03% (-$0.02)2026-07-09
Smart-Money SignalNeutral · 44/100— Insiders are net sellers over 90 days (-$43K, 15 sales vs 17 buys)
Revenue$0
Net Income-$19.7M
EPS$-0.28
Market Cap$84.1M
Price Performance
Historical data including institutional events
Company Profile
J
Jacqueline Shea, Ph.D.
CEO & Executive Director
Inovio Pharmaceuticals, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of synthetic DNA products for treating cancers and infectious diseases. In April 2020, Inovio was among some 100 companies, academic centers, or research organizations developing a vaccine candidate for treating people infected with COVID-19, with more than 170 total vaccine candidates in development.
